Research
Hormonal
Glucagon-like peptide-1 receptor agonists induce substantial and durable weight loss and improve obesity-related gastrointestinal outcomes.
Practitioners can consider GLP-1 receptor agonists as effective treatments for weight management and gastrointestinal health.
StrongSupportsmedium confidence
Glucagon-like peptide-1 receptor agonists induce substantial and durable weight loss and improve obesity-related gastrointestinal outcomes.
Why this rating
The claim is supported by a narrative review of recent clinical trials and studies.
Source
Review Article: The Evolving Role of <scp>GLP</scp> ‐1 Receptor Agonists in Gastroenterology Practice
Sydney Pomenti et al. · Alimentary Pharmacology & Therapeutics · 2025
reviewCited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →